Ignite Creation Date:
2025-12-24 @ 3:28 PM
Ignite Modification Date:
2026-01-03 @ 6:50 PM
Study NCT ID:
NCT06074692
Status:
RECRUITING
Last Update Posted:
2023-10-31
First Post:
2023-10-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)
Sponsor:
Ruijin Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-03
First Submit QC Date:
None
Study First Post Date:
2023-10-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-29
Last Update Post Date:
2023-10-31
Last Update Post Date Type:
ACTUAL